Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-0288PMID 16061671
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA single-strand break repair and spinocerebellar ataxia with axonal neuropathy-1.

  2007cited by this paper
• Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA‐PK in human cells exposed to ionizing radiation and treated with kinase inhibitors

  2005cited by this paper
• Activation of Ataxia Telangiectasia Mutated by DNA Strand Break-inducing Agents Correlates Closely with the Number of DNA Double Strand Breaks*

  2005cited by this paper
• Radiation Sensitivity, H2AX Phosphorylation, and Kinetics of Repair of DNA Strand Breaks in Irradiated Cervical Cancer Cell Lines

  2004cited by this paper
• Potentiation of Cytotoxicity of Topoisomerase I Poison by Concurrent and Sequential Treatment with the Checkpoint Inhibitor UCN-01 Involves Disparate Mechanisms Resulting in Either p53-Independent Clonogenic Suppression or p53-Dependent Mitotic Catastrophe

  2004cited by this paper
• ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation

  2004cited by this paper
• Antitumor activity of sugar‐modified cytosine nucleosides

  2004cited by this paper
• Spatial and Temporal Cellular Responses to Single-Strand Breaks in Human Cells

  2003cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• Rare forms of autosomal recessive neurodegenerative ataxia.

  2003cited by this paper
• Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions.

  2003cited by this paper
• DNA single-strand break repair and spinocerebellar ataxia.

  2003cited by this paper
• DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner.

  2003cited by this paper
• SN-38 induces cell cycle arrest and apoptosis in human testicular cancer.

  2002cited by this paper
• S Phase and G2 Arrests Induced by Topoisomerase I Poisons Are Dependent on ATR Kinase Function*

  2002cited by this paper
• Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.

  2002cited by this paper
• The production of single strand and double strand breaks in DNA in aqueous solution by vacuum UV photons below 10 eV.

  2002cited by this paper
• Structural basis for Chk1 inhibition by UCN-01.

  2002cited by this paper
• Structural Basis for Chk1 Inhibition by UCN-01*

  2002cited by this paper
• ATM and ATR: networking cellular responses to DNA damage.

  2001cited by this paper
• Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase

  2001cited by this paper
• Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation

  2001cited by this paper
• Mammalian DNA single‐strand break repair: an X‐ra(y)ted affair

  2001cited by this paper
• ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks*

  2001cited by this paper
• Purine and pyrimidine nucleoside analogs.

  2001cited by this paper
• Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'- C-cyano-2'-deoxy-1--

  2001cited by this paper
• UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, γ-H2AX formation, and Mre11 relocalization

  2001cited by this paper
• Protein-protein interactions during mammalian DNA single-strand break repair.

  2001cited by this paper
• 2′-C-Cyano-2′-deoxy-1-β-d-arabino-pentofuranosylcytosine: A Novel Anticancer Nucleoside Analog that Causes Both DNA Strand Breaks and G2 Arrest

  2001cited by this paper
• Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC).

  2001cited by this paper
• ATM: sounding the double-strand break alarm.

  2000cited by this paper
• The G(2) DNA damage checkpoint targets both Wee1 and Cdc25.

  2000cited by this paper
• Caspase 3-mediated Cleavage of p21 WAF1/CIP1 Associated with the Cyclin A-Cyclin-dependent Kinase 2 Complex Is a Prerequisite for Apoptosis in SK-HEP-1 Cells*

  2000cited by this paper
• The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01*

  2000cited by this paper
• The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

  2000cited by this paper
• Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.

  2000cited by this paper
• Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.

  1999cited by this paper
• Antitumor activity and novel DNA‐self‐strand‐breaking mechanism of CNDAC (1‐(2‐C‐cyano‐2‐deoxy‐β‐d‐ARABINO‐Pentofuranosyl) cytosine) and its N4‐palmitoyl derivative (CS‐682)

  1999cited by this paper
• Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis

  1999cited by this paper
• DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139*

  1998cited by this paper
• Cleavage of CDK Inhibitor p21Cip1/Waf1 by Caspases Is an Early Event during DNA Damage-induced Apoptosis*

  1998cited by this paper
• Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil‐DNA glycosylase with DNA

  1998cited by this paper
• Evidence supporting the activity of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentafuranosylcytosine as a terminator in enzymatic DNA-chain elongation.

  1998cited by this paper
• Oxidative Decay of DNA*

  1997cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

  1997cited by this paper
• UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.

  1996cited by this paper
• The Croonian Lecture, 1996: endogenous damage to DNA.

  1996cited by this paper
• Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.

  1993cited by this paper
• Instability and decay of the primary structure of DNA

  1993cited by this paper
• DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells.

  1992cited by this paper
• Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.

  1991cited by this paper
• A novel M phase-specific H1 kinase recognized by the mitosis-specific monoclonal antibody MPM-2.

  1991cited by this paper
• Mitosis-specific monoclonal antibody MPM-2 inhibits Xenopus oocyte maturation and depletes maturation-promoting activity.

  1989cited by this paper
• Nucleosides and nucleotides. VI. Preparation of diribonucleoside monophosphates containing 4-thiouridine.

  1973cited by this paper
• I. The Croonian Lecture

  year unknowncited by this paper

• Stereoselective synthesis of 3-oxo-2-C-branched glycosides from 2,3-unsaturated sugars via [3,3]-sigmatropic rearrangement.

  2025cites this paper
• Synthesis and in silico studies of certain benzo[f]quinoline-based heterocycles as antitumor agents

  2024cites this paper
• Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers

  2021cites this paper
• Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

  2021cites this paper
• One-pot construction of carbohydrate scaffolds mediated by metal catalysts

  2020cites this paper
• Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination

  2020cites this paper
• Cytotoxic activity and density functional theory studies of some 1,3-diphenylpyrazolyltetrahydropyrimidine derivatives

  2020cites this paper
• Utilization of cyanoacetohydrazide and 2-(1,3-dioxoisoindolin-2-yl) acetyl chloride in the synthesis of some novel anti-proliferative heterocyclic compounds

  2020cites this paper
• CNDAC-Induced DNA Double-Strand Breaks Cause Aberrant Mitosis Prior to Cell Death

  2019cites this paper
• Proposal and Practical Research for “Module Drug Discovery” Regarding Anticancer Drugs

  2018cites this paper
• Analysis of the prolonged infusion of DFP-10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo.

  2018cites this paper
• Regioselective Reactions, Spectroscopic Characterization, and Cytotoxic Evaluation of Spiro-pyrrolidine Thiophene

  2018cites this paper
• Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations

  2018cites this paper
• Efficient MW-Assisted Synthesis of Some New Isoquinolinone Derivatives With In Vitro Antitumor Activity

  2017cites this paper
• Utilization of Cyanoacetohydrazide and Oxadiazolyl Acetonitrile in the Synthesis of Some New Cytotoxic Heterocyclic Compounds

  2016influential citation
• Ortho-topolin riboside induces apoptosis in Acute myeloid leukemia HL-60 cells

  2016cites this paper
• Exploiting synthetic lethality in ovarian cancer

  2016cites this paper
• Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.

  2016cites this paper
• Sapacitabine in the treatment of acute myeloid leukemia

  2015cites this paper
• Sapacitabine in acute myelogenous leukemia

  2015cites this paper
• Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy.

  2015cites this paper
• Recent Developments in the Synthesis of 2‐C‐Branched and 1,2‐Annulated Carbohydrates

  2015cites this paper
• Novel drugs for older patients with acute myeloid leukemia

  2014cites this paper
• Methanesulfonic-Acid-Catalysed Ring Opening and Glycosylation of 1,2-(Acetylcyclopropane)-Annulated D-Lyxofuranose

  2014cites this paper
• Identification of 5-Iodotubercidin as a Genotoxic Drug with Anti-Cancer Potential

  2013cites this paper
• Sapacitabine for cancer

  2012cites this paper
• New nucleoside analogs for patients with hematological malignancies

  2011cites this paper
• Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells

  2011cites this paper
• Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.

  2010cites this paper
• Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types

  2010cites this paper
• Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

  2010cites this paper
• Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells.

  2008cites this paper
• Nucleoside analogs: molecular mechanisms signaling cell death

  2008influential citation
• [Medicinal chemistry targeting nucleosides and nucleic acids based on fine synthetic chemistry].

  2008cites this paper
• Fine synthetic nucleoside chemistry based on nucleoside natural products synthesis.

  2008cites this paper
• Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2′-C-cyano-2′-deoxy-1-β-d-arabino-pentofuranosylcytosine

  2008cites this paper
• Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.

  2008cites this paper
• Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.

  2008cites this paper
• ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity.

  2007cites this paper
• Antiproliferative effects of sapacitabine (CYC682), a novel 2′-deoxycytidine-derivative, in human cancer cells

  2007cites this paper
• Identification of a Bis-guanylhydrazone [4,4′-Diacetyldiphenylurea-bis(guanylhydrazone); NSC 109555] as a Novel Chemotype for Inhibition of Chk2 Kinase

  2007cites this paper
• Inhibition of topoisomerase IIα and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials

  2007cites this paper
• Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil

  2006cites this paper
• Antileukemic activity of sulfonamide conjugates of arabinosylcytosine.

  2006cites this paper
• Synthesis of 3'-beta-carbamoylmethylcytidine (CAMC) and its derivatives as potential antitumor agents.

  2006cites this paper
• Drug evaluation: sapacitabine--an orally available antimetabolite in the treatment of cancer.

  2006cites this paper
• Synthesis of 3′-β-carbamoylmethylcytidine (CAMC) and its derivatives as potential antitumor agents

  2006cites this paper